z-logo
open-access-imgOpen Access
Self‐Renewal of Murine Embryonic Stem Cells Is Supported by the Serine/Threonine Kinases Pim‐1 and Pim‐3
Author(s) -
Aksoy Irène,
Sakabedoyan Caline,
Bourillot PierreYves,
Malashicheva Anna B.,
Mancip Jimmy,
Knoblauch Kenneth,
Afanassieff Marielle,
Savatier Pierre
Publication year - 2007
Publication title -
stem cells
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.159
H-Index - 229
eISSN - 1549-4918
pISSN - 1066-5099
DOI - 10.1634/stemcells.2007-0066
Subject(s) - biology , embryonic stem cell , serine , threonine , kinase , microbiology and biotechnology , stem cell , protein serine threonine kinases , phosphorylation , biochemistry , protein kinase a , gene
pim‐1 and pim‐3 encode serine/threonine kinases involved in the regulation of cell proliferation and apoptosis in response to cytokine stimulation. We analyzed the regulation of pim‐1 and pim‐3 by the leukemia inhibitory factor (LIF)/gp130/signal transducer and activator of transcription‐3 (STAT3) pathway and the role of Pim‐1 and Pim‐3 kinases in mouse embryonic stem (ES) cell self‐renewal. Making use of ES cells expressing a granulocyte colony‐stimulating factor:gp130 chimeric receptor and a hormone‐dependent signal transducer and activator of transcription‐3 estrogen receptor (STAT3‐ER T2 ), we showed that expression of pim‐1 and pim‐3 was upregulated by LIF/gp130‐dependent signaling and the STAT3 transcription factor. ES cells overexpressing pim‐1 and pim‐3 had a greater capacity to self‐renew and displayed a greater resistance to LIF starvation based on a clonal assay. In contrast, knockdown of pim‐1 and pim‐3 increased the rate of spontaneous differentiation in a self‐renewal assay. Knockdown of pim‐1 and pim‐3 was also detrimental to the growth of undifferentiated ES cell colonies and increased the rate of apoptosis. These findings provide a novel role of Pim‐1 and Pim‐3 kinases in the control of self‐renewal of ES cells. Disclosure of potential conflicts of interest is found at the end of this article.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here